Mindbloom vs. Joyous vs. Nue Life: An At-Home Ketamine Comparison (2026)

If you're researching at-home ketamine therapy in 2026, you've probably landed on the same three names more than once: Mindbloom, Joyous, and Nue Life. They market to the same audience, occupy similar price points at a glance, and show up side-by-side in almost every search result. They are also three fundamentally different approaches to treatment, and the right one for you depends less on which has the best marketing and more on what you actually need clinically.

This is a physician's honest walk-through of how they differ, who each is best suited for, and the questions worth asking before you commit to any of them.

Quick summary

Mindbloom: Guided sessions with structure

Mindbloom is probably the most recognizable name in at-home ketamine, and it's the closest to what most people picture when they think "telehealth ketamine." You're prescribed sublingual RDT tablets at therapeutic doses, you do structured sessions at home — roughly one a week during the induction course — and each session is designed to be an intentional experience: eye mask, music, reflection afterward.

What works well: The session framework is solid. Mindbloom gives you enough structure that first-time patients don't end up lost in the experience. Their integration content (journaling prompts, reflection tools) is reasonable, and the UI polish is real. Dosing is adjusted across the course.

Where it's thinner: Physician involvement is network-style. You'll typically interact with a different clinician at intake than during follow-up, and the model is designed to scale across many patients per clinician. That's not inherently bad, but for patients who want continuity with a single physician who knows their history, it's a limitation. Price is mid-range at roughly $500 for a first induction course, with maintenance pricing lower.

Best for: Patients who are new to ketamine, want structured sessions with built-in integration scaffolding, and don't have complex medical comorbidities that warrant a single-prescriber relationship.

For a direct comparison with our own program, see Discreet Ketamine vs. Mindbloom.

Joyous: Daily low-dose, a different model entirely

Joyous is the outlier in this comparison, and it's important to understand how different their approach is before you compare numbers. Joyous prescribes a low daily dose of ketamine — typically in the 15 to 75 mg range — which patients take every day, or nearly every day, rather than in weekly therapeutic sessions.

The case for it: At $129/month, it's substantially cheaper than session-based programs. Some patients report real benefit, particularly for chronic low-grade depression and anxiety. The daily-dose model avoids the "big session experience," which matters for patients who find dissociation unpleasant or inconvenient.

The case against it: The clinical evidence base for daily low-dose ketamine is substantially thinner than for therapeutic-dose sessions. The mechanism that produces the durable antidepressant effect — the neuroplasticity window driven by BDNF release at therapeutic doses — may not be reliably triggered at sub-therapeutic daily doses. Daily exposure also raises different long-term questions about tolerance and dependence that session-based protocols avoid by design. This is an open clinical question in 2026, not a settled one.

Best for: Patients who want the lowest-cost option, have mild-to-moderate chronic symptoms, prefer to avoid the session experience, and are willing to be part of what is still, honestly, an unproven long-term treatment model.

Our direct comparison: Discreet Ketamine vs. Joyous.

Nue Life: Coach-led, integration-heavy

Nue Life is positioned at the premium end and leans hard on the coaching/integration side of the experience. You get the ketamine prescription, but the pitch is really about the wraparound — a dedicated coach, scheduled integration calls, breathwork and mindfulness content, and structured guidance across a full treatment arc.

What works well: For patients who want maximum support and are doing ketamine primarily as personal-development work (rather than strictly for a depression or anxiety diagnosis), the coaching model adds something real. The coaches are typically trained in integration-specific work, and having a scheduled human check-in the day after a session prevents the experience from fading unused.

Where it gets expensive: First courses often run well above $1,000. For a patient who doesn't need that level of coaching support — or who already has a therapist — you're paying a lot for a service component you may not use.

Best for: Patients who want structured integration work, don't have an existing therapeutic relationship, and see ketamine as part of a broader personal-development protocol.

Our direct comparison: Discreet Ketamine vs. Nue Life.

How to actually decide

The question I'd ask a patient trying to pick among these three isn't "which is best" — it's "which problem are you solving?"

• Are you solving for cost above all else? Joyous, knowing the caveats.
• Are you solving for "I want a structured session experience and I'm new to this"? Mindbloom.
• Are you solving for "I want maximum coaching and I don't have a therapist"? Nue Life.
• Are you solving for "I want a single physician who will know my case start to finish, even if it means only two states serve me"? That's what Discreet Ketamine does, and I'll flag the honest disclosure: I'm the founder and prescriber. We're a deliberate alternative to the network-clinician model, available in Florida and New Jersey, starting at $250 for a 1-month course. If you're in those states and the continuity-of-care aspect matters to you, it's worth a look. If you're not, or if the network model is a better fit for your life, one of the others may be the right call.

Questions to ask any of them before you commit

Regardless of which provider you're leaning toward, these questions separate good at-home ketamine programs from bad ones:

1. Who is the prescribing physician? Will I see the same person at follow-up? A name and a yes/no are the answers you want.
2. What is the dosing protocol and how is it adjusted? "Standard for most patients" is not an answer. You want to hear "we titrate based on response and side-effect profile."
3. What happens if I have a bad session? Every reputable program has an after-hours protocol. Ask to see it.
4. What are the medical contraindications you screen for? See our full contraindications list. A program that doesn't ask about cardiac history, uncontrolled BP, psychosis history, or current substance use is cutting corners.
5. What is the actual research evidence for the dosing protocol you're using? Therapeutic-dose sessions (all three of the above except Joyous) have a substantial evidence base. Daily sub-therapeutic dosing does not yet.

Any program that deflects on these questions is one to keep looking past.

The bottom line

Mindbloom is the most polished session-based option. Joyous is the cheapest but represents an unproven clinical model. Nue Life is the most coaching-heavy and the most expensive. None of them are wrong — they're just solving different problems.

If you're trying to figure out whether any at-home ketamine program is right for you in the first place, start with the contraindications guide, the at-home vs. clinic comparison, and the pricing landscape overview. Those three together will tell you whether this is a realistic next step for your situation — before the question of which provider even comes up.

Next step

If you're in Florida or New Jersey and want to know whether physician-led at-home ketamine is a fit for your specific clinical picture, the five-minute eligibility check will give you a direct answer. If the answer is no, or if one of the other providers is a better match for you, I'll say so.

Discreet Ketamine provides at-home ketamine therapy to residents of Florida and New Jersey, supervised by Dr. Ben Soffer, a board-certified physician. Compounded racemic ketamine is prescribed off-label for depression, anxiety, PTSD, and chronic pain; it is not FDA-approved for these indications.